Current Status of Antithrombotic Therapy in Patients With Breast Cancer and Atrial Fibrillation

被引：2
|
作者：
Pardo Sanz, Ana [1 ]
Rincon Diaz, Luis Miguel [1 ]
Sofia Tamayo, Alejandra [2 ]
de lara Delgado, Gregorio [3 ]
Contreras, Helena [4 ]
Zamorano Gomez, Jose Luis [1 ]
机构：
[1] Hosp Ramon & Cajal, Serv Cardiol, Madrid, Spain
[2] Hosp Gen Univ Elche, Serv Cardiol, Alicante, Spain
[3] Hosp Torrevieja, Serv Cardiol, Alicante, Spain
[4] Hosp Virgen Salud, Serv Cardiol, Toledo, Spain
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2019年 / 72卷 / 07期
关键词：
WARFARIN;
D O I：
10.1016/j.rec.2018.06.037
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：589 / 591
页数：3
相关论文
共 50 条
  • [1] NONRHEUMATIC ATRIAL-FIBRILLATION AND ANTITHROMBOTIC THERAPY - CURRENT STATUS
    LAVINA, RG
    FERNANDEZ, EL
    BALAGUER, FJG
    GUIO, SV
    REVISTA CLINICA ESPANOLA, 1995, 195 (08): : 559 - 564
  • [2] Status of Antithrombotic Therapy for Chinese Patients With Atrial Fibrillation
    Liu Yao
    Yang Yan-Min
    Zhu Jun
    Liang Yan
    Yu Li-Tian
    CIRCULATION, 2010, 122 (02) : E22 - E22
  • [3] Current status of anticoagulation in patients with breast cancer and atrial fibrillation
    Pardo Sanz, A.
    Rincon, L. M.
    Guedes Ramallo, P.
    Belarte, L.
    De Lara, G.
    Tamayo, A.
    Cruz, A.
    Contreras, H.
    Martinez, A.
    Huertas, S.
    Portero, J. J.
    Monteagudo, J. M.
    Marco, A.
    Del Prado, S.
    Zamorano, J. L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 283 - 283
  • [4] Current status of anticoagulation in patients with breast cancer and atrial fibrillation
    Pardo Sanz, Ana
    Rincon, Luis M.
    Guedes Ramallo, Paula
    Belarte Tornero, Laia Carla
    de Lara Delgado, Gregorio
    Tamayo Obregon, Alejandra
    Cruz-Utrilla, Alejandro
    Contreras Marmol, Helena
    Martinez-Camara, Andrea
    Huertas Nieto, Sergio
    Jose Portero-Portaz, Juan
    Salido Tahoces, Luisa
    Zamorano Gomez, Jose Luis
    BREAST, 2019, 46 : 163 - 169
  • [5] Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals
    Albers, GW
    Yim, JM
    Belew, KM
    Bittar, N
    Hattemer, CR
    Phillips, BG
    Kemp, S
    Hall, EA
    Morton, DJ
    Vlasses, PH
    ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (20) : 2311 - 2316
  • [6] Improving Antithrombotic Management in Patients With Atrial Fibrillation: Current Status and Perspectives
    Levi, Marcel
    Hobbs, F. D. Richard
    Jacobson, Alan K.
    Pisters, Ron
    Prisco, Domenico
    Bernardo, Artur
    Haas, Markus
    Heidrich, Jens
    Rosenberg, Matt
    Nielsen, Jorn Daisgaard
    Wuillemin, Walter A.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (06): : 527 - 542
  • [7] Optimizing antithrombotic therapy for atrial fibrillation in cancer
    Tufano, Antonella
    THROMBOSIS RESEARCH, 2022, 213 : S103 - S106
  • [8] Antithrombotic therapy: Is combination antithrombotic therapy safe for patients with atrial fibrillation?
    Myrvang H.
    Nature Reviews Cardiology, 2010, 7 (12) : 665 - 665
  • [9] Selecting antithrombotic therapy for patients with atrial fibrillation
    Tanaka-Esposito, Christine
    Chung, Mina K.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (01) : 49 - 63
  • [10] Antithrombotic therapy and bleeding complications in patients with atrial fibrillation and active cancer
    Chu, G.
    Van Rein, N.
    Huisman, M. V.
    Pedersen, L.
    Cannegieter, S. C.
    Klok, F. A.
    Sorensen, H. T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2869 - 2869
12345